FDA Investigator Emily E Krumel
Emily E Krumel has inspections in 1 countries as of 22 Sep 2023. Emily E Krumel has collaborated with a combined 1536 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
33
Last Inspection Date:
22 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alexandra A Carrico,
Allison E Sincek,
Amy L Mccarthy,
Andrew J Lang,
Annemarie Kleiza,
Anthony R Petriella,
Ashley R Karns,
Benjamin P Stewart,
Brandi N Mcgrady,
Brittany A Mckenzie,
Catherine D Djordjevic,
Chase S Baldwin,
Christi L Bellmore,
Christian L Witkovskie,
Clinton D Priestley,
Constantin Y Philopoulos,
Cynthia T Cain,
Daniel B Arrecis,
Danny Tuntevski,
Darren S Morgan,
David J Leray,
David L Craft,
Dell S Moller,
Diane M Fresch,
Dorathy M Eischen,
Edward R Kay,
Elizabeth P Mayer,
Erin M Miller,
Evan M Kupper,
Garrad R Poole,
Green,
Hassan M Fakhreddine,
Jason D Werne,
Jayne E Holcomb,
Jeffrey A Sincek,
Jennifer A Pruden,
Jennifer M Heitz,
Jessica M Wooten,
John A Daubenspeck,
Joseph R Strelnik,
Julia A Avery,
Karen M Cooper,
Kathleen D Culver,
Kathryn J Mccarty,
Keith J Mason,
Kelley L Clark,
Kelli Wilkinson,
Kimberly A Joseph,
Kirk A Dymbrowski,
Klein,
Laura A Munsterman,
Lauren E Burke,
Lauren R Collins,
Leslie A Paul,
Leslie R Clark,
Logan M Ebeling,
Luckner Jean Marie,
Maney P Sturgill,
Margaret N Persich,
Martha Sullivan Myrick,
Mary E Storch,
Matt D Suedkamp,
Matthew H Pitts,
Maureen F Alleman,
Michael D Thatcher,
Michael E Campbell,
Michael K Larson,
Michael Y Philopoulos,
Mishelle L Harriger,
Misty D Harvey,
Nadeem I Chaudhry,
Nancy L Neiger,
Pamela A Kuist,
Parul M Patel,
Pifer,
Robert G Taylor,
Robert Rodriguez,
Rosanna M Goodrich,
State Agency,
Stephen G Mclane,
Talmane J Fisher,
Tamara M Kays,
Theodore N Sietsema,
Thomas B Smith,
Tonnie L Carter,
Tracey Asinjen Wiersma,
Tracey L Siebesma
Emily E Krumel's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2023 | FDA 483 | Mead Johnson & Company LLC - Form 483, 2023-02-23 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more